Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pankajkumar Subhashchandra
An Emerging Protagonist: Sodium Glucose Co-Transporters (SGLTs) as a Burgeoning Target for the Treatment of Diabetes Mellitus
Journal of Diabetes & Metabolism
Related publications
The Potential Role of Sodium Glucose Co-Transporter 2 Inhibitors in the Early Treatment of Type 2 Diabetes Mellitus
International Journal of Clinical Practice
Medicine
Gut as an Emerging Organ for the Treatment of Diabetes
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
Drugs in Context
Molecular Medicine
Pharmacology
Sodium-Glucose Co-Transporter 2 Inhibition as a Mitochondrial Therapy for Atrial Fibrillation in Patients With Diabetes?
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Sodium-Glucose Co-Transporter 2 Inhibitors: A Review of Their Use in Older People With Type 2 Diabetes Mellitus
Journal of Pharmacy Practice and Research
Pharmacology
Pharmacy
FXR an Emerging Therapeutic Target for the Treatment of Atherosclerosis
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
MicroRNAs as an Emerging Target for Melanoma Therapy
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Challenges to Hemoglobin A1c as a Therapeutic Target for Type 2 Diabetes Mellitus
Journal of General and Family Medicine
Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally
US Endocrinology
Endocrinology
Metabolism
Diabetes